Key result
Long-term survival did not significantly differ between patients receiving CRT-PM versus CRT-D over a mean follow-up of 58 months, although CRT-D more effectively lowered the sudden death rate.
Why the study?
Does CRT-D improve all-cause mortality compared to CRT-PM in patients with heart failure?
Cohort (n=233)
Does CRT-D improve all-cause mortality compared to CRT-PM in patients with heart failure?
In a cohort of heart failure patients, CRT-D did not significantly improve long-term overall survival compared to CRT-PM, despite lowering the sudden death rate.
No takes yet. Share an insight, caveat, or question.
Similar mortality with CRT-PM versus CRT-D; hypothesis-generating and should not yet change device selection.
Stabile et al. (2009) conducted a cohort in Heart failure (n=233). CRT-PM vs. CRT-D was evaluated on all-cause mortality. Long-term survival did not significantly differ between patients receiving CRT-PM versus CRT-D over a mean follow-up of 58 months, although CRT-D more effectively lowered the sudden death rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: